The Current Ratio as of November 2024 (TTM) for Lexaria Bioscience Corp. (LEXX) is 58.27

According to Lexaria Bioscience Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 58.27. This represents a change of 50.96% compared to the average of 38.60 of the last 4 quarters.

Lexaria Bioscience Corp. (LEXX) Historical Current Ratio (quarterly & annually)

How has LEXX Current Ratio performed in the past?

The mean historical Current Ratio of Lexaria Bioscience Corp. over the last ten years is 23.99. The current 58.27 Current Ratio has changed 24.19% with respect to the historical average. Over the past ten years (40 quarters), LEXX's Current Ratio was at its highest in in the August 2021 quarter at 81.18. The Current Ratio was at its lowest in in the May 2016 quarter at 0.84.

Lexaria Bioscience Corp. (LEXX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Lexaria Bioscience Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lexaria Bioscience Corp. (LEXX) Average Current Ratio

How has LEXX Current Ratio performed in the past?

The current Current Ratio of Lexaria Bioscience Corp. (LEXX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Lexaria Bioscience Corp. (LEXX) Current Ratio vs. Peers

How is LEXX’s Current Ratio compared to its peers?

Lexaria Bioscience Corp.’s Current Ratio is greater than Revelation Biosciences, Inc. (1.64), greater than Zura Bio Limited (10.36), greater than Phio Pharmaceuticals Corp. (6.38), greater than ZyVersa Therapeutics, Inc. (0.03), greater than TransCode Therapeutics, Inc. (1.58), greater than Immix Biopharma, Inc. (3.47), greater than CNS Pharmaceuticals, Inc. (1.82), greater than eFFECTOR Therapeutics, Inc. (1.03), greater than Navidea Biopharmaceuticals, Inc. (0.56), greater than Sonnet BioTherapeutics Holdings, Inc. (1.65), greater than SeaStar Medical Holding Corporation (0.54), greater than Virios Therapeutics, Inc. (7.27), less than Biodexa Pharmaceuticals Plc (0), greater than Oncorus, Inc. (2.16), greater than null (1.74),

Build a custom stock screener for Lexaria Bioscience Corp. (LEXX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lexaria Bioscience Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lexaria Bioscience Corp. (LEXX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lexaria Bioscience Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.